Gary S Jacob - Net Worth and Insider Trading
Gary S Jacob Net Worth
The estimated net worth of Gary S Jacob is at least $98,100 dollars as of 2024-11-06. Gary S Jacob is the Director of Cardiff Oncology Inc and owns about 21,922 shares of Cardiff Oncology Inc (CRDF) stock worth over $80,892. Gary S Jacob is the CEO of OKYO Pharma Ltd and owns about 12,500 shares of OKYO Pharma Ltd (OKYO) stock worth over $14,000. Gary S Jacob is also the CEO of Synergy Pharmaceuticals Inc and owns about 402,679 shares of Synergy Pharmaceuticals Inc (SGYPQ) stock worth over $2,577. Besides these, Gary S Jacob also holds Hepion Pharmaceuticals Inc (HEPA) , Virpax Pharmaceuticals Inc (VRPX) . Details can be seen in Gary S Jacob's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gary S Jacob has not made any transactions after 2022-05-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gary S Jacob
Gary S Jacob Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gary S Jacob owns 5 companies in total, including Hepion Pharmaceuticals Inc (HEPA) , Cardiff Oncology Inc (CRDF) , and Synergy Pharmaceuticals Inc (SGYPQ) among others .
Click here to see the complete history of Gary S Jacob’s form 4 insider trades.
Insider Ownership Summary of Gary S Jacob
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HEPA | Hepion Pharmaceuticals Inc | 2020-12-01 | director & CEO and President |
| CRDF | Cardiff Oncology Inc | 2021-03-23 | director |
| SGYPQ | Synergy Pharmaceuticals Inc | 2018-06-15 | director & Executive Chairman |
 | | 2021-04-07 | director |
| | 2022-05-19 | director & Chief Executive Officer |
Gary S Jacob Latest Holdings Summary
Gary S Jacob currently owns a total of 5 stocks. Among these stocks, Gary S Jacob owns 21,922 shares of Cardiff Oncology Inc (CRDF) as of March 23, 2021, with a value of $80,892 and a weighting of 82.46%. Gary S Jacob owns 12,500 shares of OKYO Pharma Ltd (OKYO) as of May 19, 2022, with a value of $14,000 and a weighting of 14.27%. Gary S Jacob also owns 402,679 shares of Synergy Pharmaceuticals Inc (SGYPQ) as of May 26, 2017, with a value of $2,577 and a weighting of 2.63%. The other 2 stocks Hepion Pharmaceuticals Inc (HEPA) , Virpax Pharmaceuticals Inc (VRPX) have a combined weighting of 0.64% among all his current holdings.
Latest Holdings of Gary S Jacob
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2021-03-23 | 21,922 | 3.69 | 80,892 |
| OKYO | OKYO Pharma Ltd | 2022-05-19 | 12,500 | 1.12 | 14,000 |
| SGYPQ | Synergy Pharmaceuticals Inc | 2017-05-26 | 402,679 | 0.01 | 2,577 |
| HEPA | Hepion Pharmaceuticals Inc | 2020-12-01 | 603 | 0.64 | 389 |
| VRPX | Virpax Pharmaceuticals Inc | 2021-02-17 | 350 | 0.69 | 242 |
Holding Weightings of Gary S Jacob
Gary S Jacob Form 4 Trading Tracker
According to the SEC Form 4 filings, Gary S Jacob has made a total of 2 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Cardiff Oncology Inc is the acquisition of 2,370 shares on March 23, 2021, which cost Gary S Jacob around $24,695.
According to the SEC Form 4 filings, Gary S Jacob has made a total of 1 transactions in OKYO Pharma Ltd (OKYO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OKYO Pharma Ltd is the acquisition of 12,500 shares on May 19, 2022, which cost Gary S Jacob around $50,000.
According to the SEC Form 4 filings, Gary S Jacob has made a total of 0 transactions in Synergy Pharmaceuticals Inc (SGYPQ) over the past 5 years. The most-recent trade in Synergy Pharmaceuticals Inc is the acquisition of 5,680 shares on May 26, 2017, which cost Gary S Jacob around $19,994.
More details on Gary S Jacob's insider transactions can be found in the Insider Trading History of Gary S Jacob table.Insider Trading History of Gary S Jacob
- 1
Gary S Jacob Trading Performance
GuruFocus tracks the stock performance after each of Gary S Jacob's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gary S Jacob is 35.5%. GuruFocus also compares Gary S Jacob's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gary S Jacob within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gary S Jacob's insider trading performs compared to the benchmark.
Performance of Gary S Jacob
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.27 | | | | | |
| Relative Return to S&P 500(%) | 10.21 | | | | | |
Gary S Jacob Ownership Network
Ownership Network List of Gary S Jacob
Ownership Network Relation of Gary S Jacob
Gary S Jacob Owned Company Details
What does Hepion Pharmaceuticals Inc do?
Who are the key executives at Hepion Pharmaceuticals Inc?
Gary S Jacob is the director & CEO and President of Hepion Pharmaceuticals Inc. Other key executives at Hepion Pharmaceuticals Inc include Chief Scientific Officer Robert T Foster , Chief Financial Officer John T Cavan , and 10 percent owner Donald E Garlikov .
Hepion Pharmaceuticals Inc (HEPA) Insider Trades Summary
Over the past 18 months, Gary S Jacob made no insider transaction in Hepion Pharmaceuticals Inc (HEPA). Other recent insider transactions involving Hepion Pharmaceuticals Inc (HEPA) include a net purchase of 8,000 shares made by Peter Wijngaard , and a net purchase of 3,200 shares made by Robert T Foster .
In summary, during the past 3 months, insiders sold 0 shares of Hepion Pharmaceuticals Inc (HEPA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hepion Pharmaceuticals Inc (HEPA) were sold and 11,200 shares were bought by its insiders, resulting in a net purchase of 11,200 shares.
Hepion Pharmaceuticals Inc (HEPA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hepion Pharmaceuticals Inc Insider Transactions
Gary S Jacob Mailing Address
Above is the net worth, insider trading, and ownership report for Gary S Jacob. Currently GuruFocus does not have mailing address information for Gary S Jacob.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
